A new drug targeting toxic proteins in the brain shows promise in treating Alzheimer's disease. Researchers developed RI-AG03 to prevent tau protein clumping, a key factor in Alzheimer's progression. Early studies in fruit flies and cells are encouraging, but human trials are needed for further evaluation.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing